
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.4B | $1.6B | $1.6B | $1.7B | |
Revenue Growth (YoY) | -- | 16.73% | 8.57% | 4.23% | 2.55% | |
Cost of Revenues | $923.2M | $1.1B | $1.2B | $1.2B | $1.2B | |
Gross Profit | $309.4M | $349.3M | $359.2M | $432.7M | $462.1M | |
Gross Profit Margin | 25.1% | 24.28% | 23% | 26.58% | 27.68% | |
R&D Expenses | $39M | $42M | $38.6M | $42.5M | $40.6M | |
Selling, General & Admin | $112.1M | $126.2M | $139.7M | $174.7M | $187.6M | |
Other Inc / (Exp) | $42.7M | $36.3M | $36.8M | $37.4M | $43.5M | |
Operating Expenses | $151.1M | $168.2M | $183.3M | $217.9M | $230.2M | |
Operating Income | $158.3M | $181.1M | $175.9M | $214.8M | $231.9M | |
Net Interest Expenses | $400K | $800K | $700K | $25.8M | $40.6M | |
EBT. Incl. Unusual Items | $200.6M | $216.6M | $212M | $226.4M | $234.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $57.8M | $46.5M | $41.6M | $55.1M | $49.2M | |
Net Income to Company | $142.8M | $170.1M | $170.4M | $171.3M | $185.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $142.8M | $170.1M | $170.4M | $171.3M | $185.6M | |
Basic EPS (Cont. Ops) | $1.71 | $2.04 | $2.05 | $2.06 | $2.23 | |
Diluted EPS (Cont. Ops) | $1.71 | $2.04 | $2.05 | $2.05 | $2.22 | |
Weighted Average Basic Share | $83.3M | $83.3M | $83.3M | $83.3M | $83.2M | |
Weighted Average Diluted Share | $83.3M | $83.3M | $83.3M | $83.4M | $83.6M | |
EBITDA | $222.1M | $239M | $234.3M | $273.7M | $300.2M | |
EBIT | $201M | $217.4M | $212.7M | $252.2M | $275.4M | |
Revenue (Reported) | $1.2B | $1.4B | $1.6B | $1.6B | $1.7B | |
Operating Income (Reported) | $158.3M | $181.1M | $175.9M | $214.8M | $231.9M | |
Operating Income (Adjusted) | $201M | $217.4M | $212.7M | $252.2M | $275.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $382.5M | $418.6M | $426.6M | $416.5M | |
Revenue Growth (YoY) | -- | -- | 9.44% | 1.91% | -2.37% | |
Cost of Revenues | -- | $301.1M | $308.8M | $314.8M | $306M | |
Gross Profit | -- | $81.4M | $109.8M | $111.8M | $110.5M | |
Gross Profit Margin | -- | 21.28% | 26.23% | 26.21% | 26.53% | |
R&D Expenses | -- | $10.4M | $9.8M | $10.1M | $9.1M | |
Selling, General & Admin | -- | $32.5M | $39.1M | $43.3M | $45.9M | |
Other Inc / (Exp) | -- | $9.4M | $8.3M | $10.6M | $9.5M | |
Operating Expenses | -- | $45.6M | $49M | $53.6M | $54.8M | |
Operating Income | -- | $35.8M | $60.8M | $58.2M | $55.7M | |
Net Interest Expenses | -- | $200K | -- | $10.5M | $8.4M | |
EBT. Incl. Unusual Items | -- | $45M | $69.1M | $58.3M | $56.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $10.2M | $16.4M | $12.8M | $12.1M | |
Net Income to Company | -- | $34.8M | $52.7M | $45.5M | $44.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $34.8M | $52.7M | $45.5M | $44.7M | |
Basic EPS (Cont. Ops) | -- | $0.42 | $0.63 | $0.55 | $0.54 | |
Diluted EPS (Cont. Ops) | -- | $0.42 | $0.63 | $0.54 | $0.54 | |
Weighted Average Basic Share | -- | $83.3M | $83.3M | $83.3M | $82.8M | |
Weighted Average Diluted Share | -- | $83.3M | $83.3M | $83.6M | $83.2M | |
EBITDA | -- | $50.6M | $74.5M | $74.2M | $72.4M | |
EBIT | -- | $45.2M | $69.1M | $68.8M | $65.2M | |
Revenue (Reported) | -- | $382.5M | $418.6M | $426.6M | $416.5M | |
Operating Income (Reported) | -- | $35.8M | $60.8M | $58.2M | $55.7M | |
Operating Income (Adjusted) | -- | $45.2M | $69.1M | $68.8M | $65.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $1.6B | $1.6B | $1.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $1.2B | $1.2B | $1.2B | |
Gross Profit | -- | -- | $387.6M | $434.7M | $460.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $38M | $42.8M | $39.6M | |
Selling, General & Admin | -- | -- | $146.3M | $178.9M | $190.2M | |
Other Inc / (Exp) | -- | $9.4M | $35.7M | $39.7M | $42.4M | |
Operating Expenses | -- | -- | $186.7M | $222.5M | $231.4M | |
Operating Income | -- | -- | $200.9M | $212.2M | $229.4M | |
Net Interest Expenses | -- | $200K | $500K | $36.3M | $38.5M | |
EBT. Incl. Unusual Items | -- | -- | $236.1M | $215.6M | $233.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $47.8M | $51.5M | $48.5M | |
Net Income to Company | -- | -- | $188.3M | $164.1M | $184.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | $188.3M | $164.1M | $184.8M | |
Basic EPS (Cont. Ops) | -- | -- | $2.26 | $1.97 | $2.22 | |
Diluted EPS (Cont. Ops) | -- | -- | $2.26 | $1.96 | $2.21 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | $258.2M | $273.4M | $298.4M | |
EBIT | -- | -- | $236.6M | $251.9M | $271.8M | |
Revenue (Reported) | -- | -- | $1.6B | $1.6B | $1.7B | |
Operating Income (Reported) | -- | -- | $200.9M | $212.2M | $229.4M | |
Operating Income (Adjusted) | -- | -- | $236.6M | $251.9M | $271.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $382.5M | $418.6M | $426.6M | $416.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $301.1M | $308.8M | $314.8M | $306M | |
Gross Profit | -- | $81.4M | $109.8M | $111.8M | $110.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $10.4M | $9.8M | $10.1M | $9.1M | |
Selling, General & Admin | -- | $32.5M | $39.1M | $43.3M | $45.9M | |
Other Inc / (Exp) | -- | $9.4M | $8.3M | $10.6M | $9.5M | |
Operating Expenses | -- | $45.6M | $49M | $53.6M | $54.8M | |
Operating Income | -- | $35.8M | $60.8M | $58.2M | $55.7M | |
Net Interest Expenses | -- | $200K | -- | $10.5M | $8.4M | |
EBT. Incl. Unusual Items | -- | $45M | $69.1M | $58.3M | $56.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $10.2M | $16.4M | $12.8M | $12.1M | |
Net Income to Company | -- | $34.8M | $52.7M | $45.5M | $44.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $34.8M | $52.7M | $45.5M | $44.7M | |
Basic EPS (Cont. Ops) | -- | $0.42 | $0.63 | $0.55 | $0.54 | |
Diluted EPS (Cont. Ops) | -- | $0.42 | $0.63 | $0.54 | $0.54 | |
Weighted Average Basic Share | -- | $83.3M | $83.3M | $83.3M | $82.8M | |
Weighted Average Diluted Share | -- | $83.3M | $83.3M | $83.6M | $83.2M | |
EBITDA | -- | $50.6M | $74.5M | $74.2M | $72.4M | |
EBIT | -- | $45.2M | $69.1M | $68.8M | $65.2M | |
Revenue (Reported) | -- | $382.5M | $418.6M | $426.6M | $416.5M | |
Operating Income (Reported) | -- | $35.8M | $60.8M | $58.2M | $55.7M | |
Operating Income (Adjusted) | -- | $45.2M | $69.1M | $68.8M | $65.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $168M | $184.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $161.9M | $174.2M | $246.8M | $254.2M | |
Inventory | -- | $245.8M | $245M | $250M | $266.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $13.6M | $19.3M | $28.2M | $49.9M | |
Total Current Assets | -- | $482.1M | $500.3M | $693M | $755M | |
Property Plant And Equipment | -- | $141.1M | $148.4M | $174.6M | $186.2M | |
Long-Term Investments | -- | $87M | $77M | $84.8M | $84.9M | |
Goodwill | -- | $84.7M | $84.7M | $84.7M | $84.7M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $53.4M | $7.2M | $9.4M | $20.7M | |
Total Assets | -- | $848.3M | $867.4M | $1.1B | $1.2B | |
Accounts Payable | -- | $140.1M | $145.9M | $236.6M | $193.1M | |
Accrued Expenses | -- | $49.1M | $62M | $58.7M | $57.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $7.5M | $22.5M | |
Current Portion Of Capital Lease Obligations | -- | $9.8M | $9.4M | $7.4M | $12.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | $319.9M | $331M | $375M | $344.9M | |
Long-Term Debt | -- | -- | -- | $592.5M | $570M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $411.1M | $411.8M | $1B | $962.9M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | $437.2M | $455.6M | $80.7M | $227.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $437.2M | $455.6M | $80.7M | $227.4M | |
Total Liabilities and Equity | -- | $848.3M | $867.4M | $1.1B | $1.2B | |
Cash and Short Terms | -- | -- | -- | $168M | $184.3M | |
Total Debt | -- | -- | -- | $600M | $592.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $110M | $149.2M | $183.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $176.6M | $262.2M | $282.4M | |
Inventory | -- | -- | $254.5M | $256.9M | $270.8M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $20.5M | $31.1M | $46.9M | |
Total Current Assets | -- | -- | $630.4M | $699.4M | $783.4M | |
Property Plant And Equipment | -- | -- | $152.5M | $181.2M | $192.3M | |
Long-Term Investments | -- | -- | $84.1M | $83.4M | $86.9M | |
Goodwill | -- | -- | $84.7M | $84.7M | $84.7M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $7.7M | $10.4M | $19.6M | |
Total Assets | -- | -- | $1B | $1.1B | $1.2B | |
Accounts Payable | -- | -- | $175M | $236.5M | $217.8M | |
Accrued Expenses | -- | -- | $52.1M | $53.3M | $51.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $11.2M | $26.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | $10.4M | $7.7M | $14.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $369.2M | $349.4M | $351.8M | |
Long-Term Debt | -- | -- | $650M | $588.8M | $562.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $1.1B | $982.4M | $962.8M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -$53.4M | -$63M | -$74M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$96.9M | $121.8M | $265.3M | |
Total Liabilities and Equity | -- | -- | $1B | $1.1B | $1.2B | |
Cash and Short Terms | -- | -- | $110M | $149.2M | $183.3M | |
Total Debt | -- | -- | $650M | $600M | $588.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $142.8M | $170.1M | $170.4M | $171.3M | $185.6M | |
Depreciation & Amoritzation | $21.1M | $21.6M | $21.6M | $21.5M | $24.8M | |
Stock-Based Compensation | -- | -- | -- | $7.2M | $11.9M | |
Change in Accounts Receivable | -$11.9M | -$7.8M | -$18.3M | -$10.1M | -$16.8M | |
Change in Inventories | $6.1M | -$43.5M | -$9.7M | -$4.3M | -$25.4M | |
Cash From Operations | $213.1M | $209.9M | $165.7M | $189M | $105.4M | |
Capital Expenditures | $26.5M | $33.4M | $37.5M | $45.8M | $48.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$26.5M | -$33.4M | -$37.5M | -$45.8M | -$48.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$8.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $650M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$50M | -$7.5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$20M | |
Other Financing Activities | -$186.6M | -- | -$128.2M | -$575.2M | -- | |
Cash From Financing | -$186.6M | -$176.5M | -$128.2M | $24.8M | -$35.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | $168M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $168M | $21M | |
Ending Cash (CF) | -- | -- | -- | $168M | $184.3M | |
Levered Free Cash Flow | $186.6M | $176.5M | $128.2M | $143.2M | $56.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $34.8M | $52.7M | $45.5M | $44.7M | |
Depreciation & Amoritzation | -- | $5.4M | $5.4M | $5.4M | $7.2M | |
Stock-Based Compensation | -- | -- | -- | $2M | $2.3M | |
Change in Accounts Receivable | -- | -$28.7M | -$4.6M | -$18.2M | -$24.9M | |
Change in Inventories | -- | -$18.4M | -$9.7M | -$9.6M | -$1.1M | |
Cash From Operations | -- | $2.8M | $42.8M | -$8.2M | $28.7M | |
Capital Expenditures | -- | $4.9M | $6.4M | $10.6M | $12.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$4.9M | -$6.4M | -$10.6M | -$12.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$4.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$3.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$10M | |
Other Financing Activities | -- | $2.1M | -$36.4M | -- | -- | |
Cash From Financing | -- | $2.1M | -$36.4M | -- | -$17.9M | |
Beginning Cash (CF) | -- | -- | -- | $168M | $184.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $600K | |
Additions / Reductions | -- | -- | -- | -$18.8M | -$1.6M | |
Ending Cash (CF) | -- | -- | -- | $149.2M | $183.3M | |
Levered Free Cash Flow | -- | -$2.1M | $36.4M | -$18.8M | $16.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $188.3M | $164.1M | $184.8M | |
Depreciation & Amoritzation | -- | -- | $21.6M | $21.5M | $26.6M | |
Stock-Based Compensation | -- | -- | -- | $2M | $12.2M | |
Change in Accounts Receivable | -- | -- | $5.8M | -$23.7M | -$23.5M | |
Change in Inventories | -- | -- | -$1M | -$4.2M | -$16.9M | |
Cash From Operations | -- | -- | $205.7M | $138M | $142.3M | |
Capital Expenditures | -- | $4.9M | $39M | $50M | $50.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$39M | -$50M | -$50.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$12.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$166.7M | -- | -- | |
Cash From Financing | -- | -- | -$166.7M | $61.2M | -$53.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $149.2M | $38.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | $166.7M | $88M | $91.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $34.8M | $52.7M | $45.5M | $44.7M | |
Depreciation & Amoritzation | -- | $5.4M | $5.4M | $5.4M | $7.2M | |
Stock-Based Compensation | -- | -- | -- | $2M | $2.3M | |
Change in Accounts Receivable | -- | -$28.7M | -$4.6M | -$18.2M | -$24.9M | |
Change in Inventories | -- | -$18.4M | -$9.7M | -$9.6M | -$1.1M | |
Cash From Operations | -- | $2.8M | $42.8M | -$8.2M | $28.7M | |
Capital Expenditures | -- | $4.9M | $6.4M | $10.6M | $12.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$4.9M | -$6.4M | -$10.6M | -$12.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$4.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$3.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$10M | |
Other Financing Activities | -- | $2.1M | -$36.4M | -- | -- | |
Cash From Financing | -- | $2.1M | -$36.4M | -- | -$17.9M | |
Beginning Cash (CF) | -- | -- | -- | $168M | $184.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $600K | |
Additions / Reductions | -- | -- | -- | -$18.8M | -$1.6M | |
Ending Cash (CF) | -- | -- | -- | $149.2M | $183.3M | |
Levered Free Cash Flow | -- | -$2.1M | $36.4M | -$18.8M | $16.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.